Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

Ontology Browser
Term:
[(R)-1-L-prolylpyrrolidin-2-yl]boronic acid (CHEBI:41285)
Annotations: Rat: (0) Mouse: (0) Human: (0) Chinchilla: (0) Bonobo: (0) Dog: (0) Squirrel: (0) Pig: (0) Naked Mole-rat: (0) Green Monkey: (0)
Parent Terms Term With Siblings Child Terms
(1R)-1-\{[(1-\{N-[(S)-hydroxy(morpholin-4-yl)methyl]-beta-phenyl-D-phenylalanyl\}-1H-pyrrol-2-yl)carbonyl]amino\}-4-methoxybutylboronic acid 
(1R)-3-methyl-1-\{[N-(morpholin-4-ylcarbonyl)-3-(1-naphthyl)-D-alanyl]amino\}butylboronic acid 
(1S)-2-[(2S,5R)-2-(aminomethyl)-5-ethynylpyrrolidin-1-yl]-1-cyclopentyl-2-oxoethanamine 
(1S)-2-[(2S,5R)-2-(aminomethyl)-5-prop-1-yn-1-ylpyrrolidin-1-yl]-1-cyclopentyl-2-oxoethanamine 
(1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine 
(2S)-2-amino-3-(2-boronoethylthio)propanoic acid 
(2S)-2-cyano-1-(4-phenyl-L-phenylalanyl)pyrrolidine 
(2S)-3-(3-pyridyl)propyl 1-(3,3-dimethyl-1,2-dioxopentyl)pyrrolidine-2-carboxylate 
(2S)-3-(7-carbamimidoylnaphthalen-2-yl)-2-[4-(\{(3R)-1-[(1Z)-ethanimidoyl]pyrrolidin-3-yl\}oxy)phenyl]propanoic acid 
(2S)-3-methyl-2-((2R,3S)-3-[(methylsulfonyl)amino]-1-\{[2-(pyrrolidin-1-ylmethyl)-1,3-oxazol-4-yl]carbonyl\}pyrrolidin-2-yl)butanoic acid 
(2S,3S)-3-\{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl\}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine 
(2S,4R)-1-acetyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(benzothiazol-2-ylcarbonyl)butyl]-4-hydroxypyrrolidine-2-carboxamide 
(2S,4S,5R)-1-(4-tert-butylbenzoyl)-2-isobutyl-5-(1,3-thiazol-2-yl)pyrrolidine-2,4-dicarboxylic acid 
(2S,4S,5R)-2-isobutyl-5-(2-thienyl)-1-[4-(trifluoromethyl)benzoyl]pyrrolidine-2,4-dicarboxylic acid 
(3S)-1-[(E)-amino(imino)methyl]-N-(\{(2S)-1-[N-(2-naphthylsulfonyl)-L-seryl]pyrrolidin-2-yl\}methyl)piperidine-3-carboxamide 
(3S)-1-\{[(3,5-dimethylisoxazol-4-yl)amino]carbonyl\}-4,4-dimethylpyrrolidin-3-yl \{(1S)-1-[1-hydroxy-2-oxo-2-\{[(1R)-1-phenylethyl]amino\}ethyl]pentyl\}carbamate 
(3S,4S)-3,4-dihydroxy-L-proline 
(4S)-1-[(4-butoxyphenyl)sulfonyl]-N-hydroxy-4-[(methylsulfonyl)amino]-D-prolinamide 
(4S)-N-hydroxy-4-(methoxyamino)-1-[(4-methoxyphenyl)sulfonyl]-D-prolinamide 
(5S)-5-(carboxymethyl)-L-proline 
(\{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino\}methyl)boronic acid 
(E)-1-[2-(Hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione 
(R)-4-hydroxy-1-methyl-L-proline 
1-(3-mercapto-2-methylpropionyl)pyrrolidine-2-carboxylic acid 
1-[(2E,4E)-2,4-decadienoyl]pyrrolidine 
1-[(2E,4E)-2,4-dodecadienoyl]pyrrolidine 
1-[(2E,4E,6E)-2,4,6-dodecatrienoyl]pyrrolidine 
1-[(2R)-2-amino-2-cyclohexylacetyl]-N-\{5-chloro-2-[2-(ethylamino)-2-oxoethoxy]benzyl\}-L-prolinamide 
1-[(3aR)-5-\{[3-(2,4-difluorophenyl)-5,6-dihydroimidazo[1,5-a]pyrazin-7(8H)-yl]carbonyl\}-6-methoxy-3aH-pyrrolo[2,3-b]pyridin-3-yl]-2-[(3R)-3-hydroxypyrrolidin-1-yl]-2-oxoethanone 
1-[2-[3-(1-propan-2-ylsulfonylazetidin-3-yl)-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl]ethanone 
1-[3,3-dimethyl-2-(2-2-methylaminopropionylamino)butyryl]-4-phenoxypyrrolidine-2-[N-(1,2,3,4-tetrahydronaphthalen-1-yl)]carboxamide 
1-\{[1-(2-amino-3-phenylpropionyl)pyrrolidine-2-carbonyl]amino\}-2-(3-cyanophenyl)ethaneboronic acid 
1-propanoylproline 
13-O-methylviriditin 
2-(2-amino-1,3-thiazol-4-yl)-2-(1-carboxy-1-methylethoxyimino)acetylaminomethylboronic acid 
2-[4-(\{(S)-1-[((S)-2-\{[(RS)-3,3,3-trifluoro-1-isopropyl-2-oxopropyl]aminocarbonyl\}pyrrolidin-1-yl)carbonyl]-2-methylpropyl\}aminocarbonyl)benzoylamino]acetic acid 
2-[4-(\{2-[(2S,5R)-2-(aminomethyl)-5-ethynylpyrrolidin-1-yl]-2-oxoethyl\}amino)-4-methylpiperidin-1-yl]isonicotinic acid 
2-amino-3-methyl-1-pyrrolidin-1-ylbutan-1-one 
3'-L-prolyl-AMP 
3-acetylphenylboronic acid 
3-hydroxy-L-proline +  
4-\{[(2R,5S)-5-\{[(2S)-2-(aminomethyl)pyrrolidin-1-yl]carbonyl\}pyrrolidin-2-yl]methoxy\}-3-tert-butylbenzoic acid 
4-\{[(E)-amino(imino)methyl]amino\}-N-(\{(2S)-1-[N-(2-naphthylsulfonyl)-L-seryl]pyrrolidin-2-yl\}methyl)butanamide 
4-hydroxy-L-proline +  
4-O-(beta-L-Araf)-cis-L-Hyp 
4-O-(beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf)-cis-L-Hyp 
4-oxo-L-proline 
5-oxo-L-proline +   
5-oxo-L-proline 2-naphthylamide 
6-(4-\{(1S,2S)-2-amino-1-[(dimethylamino)carbonyl]-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropyl\}phenyl)-1H-[1,2,4]triazolo[1,5-a]pyridin-4-ium 
[(R)-1-L-prolylpyrrolidin-2-yl]boronic acid 
An N-acylpyrrolidine obtained by formal condenstion of the carboxy group of L-proline and the secondary amino group of (R)-pyrrolidine-2-carboxylic acid.
\{(2S,3S,4S)-2-carboxy-4-[(1Z,3E,5R)-5-carboxy-1-methylhexa-1,3-dienyl]pyrrolidin-3-yl\}acetic acid 
aculene A 
aculene B 
alpha-Allokainic acid 
aniracetam  
beta-phenyl-D-phenylalanyl-N-(2,5-dichlorobenzyl)-L-prolinamide 
boronic acid +   
C-terminal boronic acid peptide +  
captopril +   
celesticetin 
dainic acid A 
dextromoramide 
domoic acid  
EC 3.4.11.* (aminopeptidase) inhibitor +   
EC 3.4.13.* (dipeptidase) inhibitor +   
EC 3.4.14.* (dipeptidyl- and tripeptidyl-peptidases) inhibitor +   
EC 3.4.15.* (peptidyl-dipeptidase) inhibitor +   
EC 3.4.17* (metallocarboxypeptidase) inhibitor +  
EC 3.4.19.* (omega-peptidase) inhibitor +   
EC 3.4.21.* (serine endopeptidase) inhibitor +   
EC 3.4.22.* (cysteine endopeptidase) inhibitor +   
EC 3.4.23.* (aspartic endopeptidase) inhibitor +   
EC 3.4.24.* (metalloendopeptidase) inhibitor +   
elbasvir +  
Formosusin A 
Formosusin B 
Formosusin C 
fosinopril  
fosinoprilat +   
isodomoic acid A 
Isomalyngamide B 
ixazomib +   
kainic acid +   
L-hydroxyproline 2-naphthylamide 
L-prolinamide 
L-proline 2-naphthylamide 
LCL161  
ledipasvir +   
lincomycin +   
LSM-1512 
malyngamide B 
matrix metalloproteinase inhibitor +   
methyl 1-methyl-5-oxo-L-prolinate 
methyl 4-\{[(\{[(2R,5S)-5-\{[(2S)-2-(aminomethyl)pyrrolidin-1-yl]carbonyl\}pyrrolidin-2-yl]methyl\}amino)carbonyl]amino\}benzoate 
N(2)-[(benzyloxy)carbonyl]-N(1)-((3R)-1-\{N-[(benzyloxy)carbonyl]-L-leucyl\}-4-oxopyrrolidin-3-yl)-L-leucinamide 
N-(14-Methylhexadecanoyl)pyrrolidine 
N-(2,4-dinitrophenyl)-L-proline 
N-(2-methyl-3-oxodecanoyl)pyrrolidine 
N-(\{(2S)-1-[(3R)-3-amino-4-(2-fluorophenyl)butanoyl]pyrrolidin-2-yl\}methyl)benzamide 
N-(trans-4-\{(1S,2S)-2-amino-3-[(3S)-3-fluoropyrrolidin-1-yl]-1-methyl-3-oxopropyl\}cyclohexyl)-N-methylacetamide 
N-[(2R,3S)-1-((2S)-2-\{[(cyclopentylamino)carbonyl]amino\}-3-methylbutanoyl)-2-(1-formylcyclobutan-1-yl)pyrrolidin-3-yl]cyclopropanecarboxamide 
N-[4-(D-prolinosulfonyl)benzoyl]-L-glutamic acid 
N-[4-(morpholin-4-ylcarbonyl)benzoyl]-L-valyl-N-[(3S)-5,5,6,6,6-pentafluoro-2-methyl-4-oxohexan-3-yl]-L-prolinamide 
N-\{(2S,3R)-2-[(1S)-1-formyl-2-methylpropyl]-1-[(2E)-4-piperidin-1-ylbut-2-enoyl]pyrrolidin-3-yl\}methanesulfonamide 
N-acetyl-D-proline 
N-acetyl-L-proline +  
N-Acetylhomoproline 
N-acetylpyrrolidine 
N-acetyltryptophyl-N(1)-\{3-[1-(N-acetyltryptophylvalyl)pyrrolidin-2-yl]-1-benzyl-2,3-dihydroxypropyl\}valinamide 
N-benzyloxycarbonyl-L-prolyl-L-prolinal 
N-ethoxycarbonyl-D-phenylalanylprolyl-2-(4-aminobutyl)hydrazine 
N-Hexadecanoylpyrrolidine 
N-methylproline 
N-Nitrosohydroxyproline 
N-Nitrosoproline 
Nosperin 
numidargistat 
PF-956980  
PHA-665752  
phenylboronic acid +  
piperyline 
protease inhibitor +   
Scalusamide B 
Scalusamide C 
Talarotoxin 
tert-butyl \{1-[2-(1-formylpropyl)-3-methanesulfonylaminopyrrolidine-1-carbonyl]-2-methylpropyl\}carbamate 
Variotin 
velpatasvir +  
Viriditin 
XJB-5-131 
zofenopril 
zofenoprilat 

Synonyms
Exact Synonyms: [(2R)-1-L-prolylpyrrolidin-2-yl]boronic acid
Related Synonyms: Formula=C9H17BN2O3 ;   InChI=1S/C9H17BN2O3/c13-9(7-3-1-5-11-7)12-6-2-4-8(12)10(14)15/h7-8,11,14-15H,1-6H2/t7-,8-/m0/s1 ;   InChIKey=XSBZZZGVAIXJLD-YUMQZZPRSA-N ;   Pro-boroPro ;   SMILES=OB(O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1
Xrefs: PDBeChem:BPR ;   PMID:10098663 ;   PMID:1353423 ;   PMID:16330047 ;   PMID:1671716 ;   PMID:16802131 ;   PMID:7780144 ;   PMID:7892748 ;   PMID:7910536 ;   PMID:7918465 ;   PMID:8103356 ;   Reaxys:14528096

paths to the root